Overview
Infectious Disease Regulatory Landscape
The regulatory environment for infectious disease therapies involves specialized requirements from FDA Division of Antivirals, EMA Anti-Infectives Working Party, PMDA Infectious Disease Division. This guide maps each requirement to ArcaScience's platform capabilities, demonstrating how AI-driven benefit-risk analysis aligns with and accelerates regulatory compliance.
Regulatory Requirements
Key Requirements by Agency
FDA Requirements
- ✓ Emergency Use Authorization evidence standards
- ✓ Antiviral drug development guidance
- ✓ Vaccine safety assessment requirements
- ✓ Antimicrobial resistance considerations
- ✓ Long-acting injectable drug development guidance
EMA Requirements
- ✓ Conditional marketing authorization for infectious diseases
- ✓ Vaccine safety monitoring requirements
- ✓ Antiviral resistance monitoring guidance
- ✓ Pandemic preparedness regulatory framework
PMDA Requirements
- ✓ Japan-specific vaccine safety monitoring
- ✓ Antiviral drug safety assessment
- ✓ Emergency approval pathway for infectious diseases
ArcaScience Alignment
How ArcaScience Maps to Infectious Disease Requirements
Data Coverage
Infectious Disease-specific data from 47+ global sources, pre-harmonized and validated for regulatory submissions.
AI Models
Infectious Disease-trained AI models for adverse event classification, signal detection, and benefit quantification with regulatory validation.
Regulatory Outputs
Pre-formatted outputs aligned with FDA Division of Antivirals and EMA Anti-Infectives Working Party submission requirements.
Download
Get the Full Infectious Disease Regulatory Landscape
Complete the form below to receive the document via email.
Related Resources